(NASDAQ:WBA) that has shown a discernible change in trend levels over the path of recent market activity. The firm purchased 73,800 shares of the pharmacy operator's stock, valued at approximately $5,779,000.
Other hedge funds also recently modified their holdings of the company.
Walgreens also said it would review its USA stores network, following its acquisition of almost 2,000 Rite Aid Corp drugstores. China Petroleum & Chemical Corp (ADR) (NYSE:SNP) has risen 24.29% since October 26, 2016 and is uptrending. A P/B ratio of less than 1.0 can indicate that a stock is undervalued, while a ratio of greater than 1.0 may indicate that a stock is overvalued. Institutional investors and hedge funds own 60.19% of the company's stock. Finally, UBS Asset Management Americas Inc. raised its stake in shares of Walgreens Boots Alliance by 22.9% in the 1st quarter.
Looking into last 5 trades, the stock observed a return of nearly 2.39%. (NASDAQ:WBA), stock is trading $88.00 above the 52-week high and has displayed a high EPS growth of 5.40% in last 5 years. (NASDAQ:WBA) opened at 69.36 on Thursday. Walgreens Boots Alliance, Inc. The Beta factor for the stock is listed at 1.58. RBC Capital Markets maintained Walgreens Boots Alliance Inc (NASDAQ:WBA) on Wednesday, September 20 with "Outperform" rating. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The business had revenue of $30.15 billion during the quarter, compared to the consensus estimate of $29.93 billion. During the same quarter in the prior year, the firm earned $1.07 EPS. The business's revenue was up 5.3% compared to the same quarter past year.
Walgreens Boots Alliance, Inc. has 1.06 billion shares outstanding, and in the last trade has seen ATR around 1.53. The company was maintained on Tuesday, September 5 by Jefferies. Shareholders of record on Friday, August 19th were paid a $0.375 dividend. The stock's Dividend Yield stands at 2.31%.
Walgreens also formed a venture with Prime, called AllianceRX Walgreens Prime, to handle mail orders and specialty prescriptions for their combined customers. Current trading movement for the stock has attracted a bevy of interest from several analysts, most weighing in on the outlook and upside for the stock in one way or another. Goldman Sachs Group, Inc. Many traders will use moving averages for different periods of time in conjunction with other indicators to help gauge future stock price action. Their average price target spell out an upbeat performance - a 29% and would give WBA a market capitalization of almost $94.62B. Morgan Stanley reissued an "overweight" rating and issued a $95.00 target price on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. On a weekly basis, the stock is 7.91%. Two research analysts have rated the stock with a sell rating, six have given a hold rating and fifteen have issued a buy rating to the company's stock. Walgreens Boots Alliance presently has an average rating of "Buy" and an average target price of $88.39.